Australian University Rankings Guide

Advances In Dual Diagnosis: Policy Practice And Research In Mental Health And Substance Use (ERA Journal)

Advances In Dual Diagnosis: Policy Practice And Research In Mental Health And Substance Use is an ERA accredited research journal used as part of the evaluation of the ERA research rankings.

Advances In Dual Diagnosis: Policy Practice And Research In Mental Health And Substance Use issns are issn1: 1757-0972 issn2: 2042-8324.

The fields covered by Advances In Dual Diagnosis: Policy Practice And Research In Mental Health And Substance Use as part of the evaluation of Australian university research excellence are:

Public Health and Health Services Research Rankings (Sub-Field)

Social Work Research Rankings (Sub-Field)

Law Research Rankings (Sub-Field)

Other ERA-accredited journals supporting the evaluation of the Public Health and Health Services field include:

- Addiction Research and Theory
- American Journal of Medical Quality
- Annals of Occupational Hygiene
- Asia Pacific Journal of Counselling and Psychotherapy
- Ciencia e Saude Coletiva
- Clinical Governance: an international journal
- Evidence-Based Healthcare and Public Health
- Forum for Health Economics and Policy
- Hospital Pediatrics
- International Journal of Infectious Diseases
- Journal of HIV/AIDS and Social Services
- Malaria Journal
- Pathogens and Global Health
- Sleep Health
- Substance Use and Misuse


ERA Research Rankings Submenu


- ERA 2018 Outcomes Research Rankings List

- ERA 2018 Research Rankings Analysis

- ERA 2018 Individual University Outcomes List

- ERA List of Research Fields Rankings

- ERA Journal Rankings 2018 List



Latest News and Updates:


- Top 10 Best Australian Universities

- Gender Balance Male-Female Ratio

- ERA 2018 Outcomes Research Rankings List

- University Bachelor Degree Completion Rates

- QS Employability Rankings Australian Universities

- ARWU World Rankings of Australian Universities

- Group of Eight (go8) World Rankings

Share This Page

  • Share on Facebook1
  • Share on Twitter2
  • Share on Linkedin3
  • Share on Reddit4